Lucas Liaudet

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


272 publications

... | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1993 |
 
Topical administration of a novel nitric oxide donor, linear polyethylenimine-nitric oxide/nucleophile adduct (DS1), selectively increases vaginal blood flow in anesthetized rats
Pacher P., Mabley J. G., Liaudet L., Evgenov O. V., Southan G. J., Abdelkarim G. E., Szabo C., Salzman A. L., 2003/12. International Journal of Impotence Research, 15 (6) pp. 461-4.
 
Endurance training enhances vasodilation induced by nitric oxide in human skin
Boegli Y., Gremion G., Golay S., Kubli S., Liaudet L., Leyvraz P. F., Waeber B., Feihl F., 2003/11. Journal of Investigative Dermatology, 121 (5) pp. 1197-204. Peer-reviewed.
 
Respiratory complications of gastroesophageal reflux associated with paraesophageal hiatal hernia
Greub G., Liaudet L., Wiesel P., Bettschart V., Schaller M. D., 2003/08. Journal of Clinical Gastroenterology, 37 (2) pp. 129-31.
 
Oxidative stress and regional ischemia-reperfusion injury: the peroxynitrite-poly(ADP-ribose) polymerase connection.
Liaudet L., Szabó G., Szabó C., 2003/04. Coronary artery disease, 14 (2) pp. 115-122. Peer-reviewed.
 
Role of poly(adenosine diphosphate-ribose) polymerase 1 in septic peritonitis.
Liaudet L., Oddo M., 2003/04. Current Opinion in Critical Care, 9 (2) pp. 152-158. Peer-reviewed.
 
Endothelium-dependent vasodilation in the skin microcirculation of patients with septic shock.
Kubli S., Boëgli Y., Ave A.D., Liaudet L., Revelly J.P., Golay S., Broccard A., Waeber B., Schaller M.D., Feihl F., 2003/03. Shock, 19 (3) pp. 274-280. Peer-reviewed.
 
Flagellin from gram-negative bacteria is a potent mediator of acute pulmonary inflammation in sepsis.
Liaudet L., Szabó C., Evgenov O.V., Murthy K.G., Pacher P., Virág L., Mabley J.G., Marton A., Soriano F.G., Kirov M.Y. et al., 2003/02. Shock, 19 (2) pp. 131-137. Peer-reviewed.
 
Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction
Pacher P., Liaudet L., Bai P., Mabley J. G., Kaminski P. M., Virag L., Deb A., Szabo E., Ungvari Z., Wolin M. S. et al., 2003/02. Circulation, 107 (6) pp. 896-904.
 
Inosine reduces inflammation and improves survival in a murine model of colitis.
Mabley J.G., Pacher P., Liaudet L., Soriano F.G., Haskó G., Marton A., Szabo C., Salzman A.L., 2003/01. American Journal of Physiology. Gastrointestinal and Liver Physiology, 284 (1) pp. G138-144. Peer-reviewed.
 
Relapsing acute respiratory failure induced by minocycline.
Oddo M., Liaudet L., Lepori M., Broccard A.F., Schaller M.D., 2003. Chest, 123 (6) pp. 2146-8. Peer-reviewed.
 
Rupture spontanée de la rate au cours de la malaria traitée par embolisation de l’artère splénique
Ribordy V., Liaudet L., 2003. Schweizerisches Medizin-Forum, 20 p. 479.
 
Role of poly(ADP-ribose) polymerase activation in endotoxin-induced cardiac collapse in rodents
Pacher P., Cziraki A., Mabley J. G., Liaudet L., Papp L., Szabo C., 2002/12. Biochemical Pharmacology, 64 (12) pp. 1785-91.
 
Part II: beneficial effects of the peroxynitrite decomposition catalyst FP15 in murine models of arthritis and colitis
Mabley J. G., Liaudet L., Pacher P., Southan G. J., Groves J. T., Salzman A. L., Szabo C., 2002/10. Molecular Medicine, 8 (10) pp. 581-90.
 
Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure
Pacher P., Liaudet L., Mabley J., Komjati K., Szabo C., 2002/09. Journal of the American College of Cardiology, 40 (5) pp. 1006-16.
 
The Flagellin-TLR5 Axis: Therapeutic Opportunities
Liaudet L., Deb A., Pacher P., Mabley J. G., Murthy K. G., Salzman A. L., Szabo C., 2002/09. Drug News Perspect, 15 (7) pp. 397-409.
 
Spontaneous rupture of the spleen during malaria treated with transcatheter coil embolization of the splenic artery
Ribordy V., Schaller M. D., Martinet O., Doenz F., Liaudet L., 2002/07. Intensive Care Medicine, 28 (7) p. 996.
 
Activation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging
Pacher P., Mabley J. G., Soriano F. G., Liaudet L., Szabo C., 2002/06. International Journal of Molecular Medicine, 9 (6) pp. 659-64.
 
NFkappaB1 (p50)-deficient mice are not susceptible to multiple low-dose streptozotocin-induced diabetes
Mabley J. G., Hasko G., Liaudet L., Soriano F., Southan G. J., Salzman A. L., Szabo C., 2002/06. Journal of Endocrinology, 173 (3) pp. 457-64.
 
Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents
Jagtap P., Soriano F. G., Virag L., Liaudet L., Mabley J., Szabo E., Hasko G., Marton A., Lorigados C. B., Gallyas, F., Jr. et al., 2002/05. Critical Care Medicine, 30 (5) pp. 1071-82.
 
Inosine exerts a broad range of antiinflammatory effects in a murine model of acute lung injury
Liaudet L., Mabley J. G., Pacher P., Virag L., Soriano F. G., Marton A., Hasko G., Deitch E. A., Szabo C., 2002/04. Annals of Surgery, 235 (4) pp. 568-78.
 
Resistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1-deficient mice
Soriano F. G., Liaudet L., Szabo E., Virag L., Mabley J. G., Pacher P., Szabo C., 2002/04. Shock, 17 (4) pp. 286-92.
 
Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure
Pacher P., Liaudet L., Bai P., Virag L., Mabley J. G., Hasko G., Szabo C., 2002/03. Journal of Pharmacology and Experimental Therapeutics, 300 (3) pp. 862-7.
 
Endothelial dysfunction in aging animals: the role of poly(ADP-ribose) polymerase activation
Pacher P., Mabley J. G., Soriano F. G., Liaudet L., Komjati K., Szabo C., 2002/03. British Journal of Pharmacology, 135 (6) pp. 1347-50.
 
Poly(adenosine 5'-diphosphate) ribose polymerase activation as a cause of metabolic dysfunction in critical illness
Liaudet L., 2002/03. Current Opinion in Clinical Nutrition and Metabolic Care, 5 (2) pp. 175-84.
 
Activation of poly(ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation
Liaudet L., Pacher P., Mabley J. G., Virag L., Soriano F. G., Hasko G., Szabo C., 2002/02. American Journal of Respiratory and Critical Care Medicine, 165 (3) pp. 372-7.
 
The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes
Pacher P., Liaudet L., Soriano F. G., Mabley J. G., Szabo E., Szabo C., 2002/02. Diabetes, 51 (2) pp. 514-21.
 
Comparison of inflammation, organ damage, and oxidant stress induced by Salmonella enterica serovar Muenchen flagellin and serovar Enteritidis lipopolysaccharide
Liaudet L., Murthy K. G., Mabley J. G., Pacher P., Soriano F. G., Salzman A. L., Szabo C., 2002/01. Infection and Immunity, 70 (1) pp. 192-8.
 
Myocardial Ischemia-reperfusion Injury: Role of the Peroxynitrite-poly(ADP-ribose) Polymerase Pathway
Szabó C., Liaudet L., 2002. pp. 165-176 dans Intensive Care Medicine, Springer New York.
 
Poly(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation
Szabo G., Bahrle S., Stumpf N., Sonnenberg K., Szabo E. E., Pacher P., Csont T., Schulz R., Dengler T. J., Liaudet L. et al., 2002/01. Circulation Research, 90 (1) pp. 100-6.
 
Role of poly(ADP-ribose) polymerase activation in septic shock
Liaudet L., 2002. Advances in Sepsis, 2 pp. 86-93.
 
Rôle de la poly(ADP-ribose) polymérase dans le choc et l'ischémie-reperfusion
Liaudet L., 2002. Revue Médicale Suisse, 2 p. 22471.
 
Surproduction d'oxyde nitrique dans le choc septique : une cible thérapeutique ?
Feihl F., Liaudet L., 2002. Médecine et Hygiène, 60 p. 1894.
 
Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase
Mabley J. G., Jagtap P., Perretti M., Getting S. J., Salzman A. L., Virag L., Szabo E., Soriano F. G., Liaudet L., Abdelkarim G. E. et al., 2001/11. Inflammation Research, 50 (11) pp. 561-9.
 
Inosine reduces systemic inflammation and improves survival in septic shock induced by cecal ligation and puncture
Liaudet L., Mabley J. G., Soriano F. G., Pacher P., Marton A., Hasko G., Szabo C., 2001/10. American Journal of Respiratory and Critical Care Medicine, 164 (7) pp. 1213-20.
 
Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase
Soriano F. G., Pacher P., Mabley J., Liaudet L., Szabo C., 2001/10. Circulation Research, 89 (8) pp. 684-91.
 
Is nitric oxide overproduction the target of choice for the management of septic shock?
Feihl F., Waeber B., Liaudet L., 2001/09. Pharmacology and Therapeutics, 91 (3) pp. 179-213.
 
Bilateral breast necrosis after prone position ventilation
Burdet L., Liaudet L., Schaller M. D., Broccard A. F., 2001/08. Intensive Care Medicine, 27 (8) p. 1435.
 
Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: long-term morphological and functional consequences
Liaudet L., Szabo E., Timashpolsky L., Virag L., Cziraki A., Szabo C., 2001/08. British Journal of Pharmacology, 133 (8) pp. 1424-30.
 
Myocardial ischemic preconditioning in rodents is dependent on poly (ADP-ribose) synthetase
Liaudet L., Yang Z., Al-Affar E. B., Szabo C., 2001/06. Molecular Medicine, 7 (6) pp. 406-17.
 
Inosine improves gut permeability and vascular reactivity in endotoxic shock
Garcia Soriano F., Liaudet L., Marton A., Hasko G., Batista Lorigados C., Deitch E. A., Szabo C., 2001/04. Critical Care Medicine, 29 (4) pp. 703-8.
 
Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation
Garcia Soriano F., Virag L., Jagtap P., Szabo E., Mabley J. G., Liaudet L., Marton A., Hoyt D. G., Murthy K. G., Salzman A. L. et al., 2001/01. Nature Medicine, 7 (1) pp. 108-13.
 
Flagellin, a novel mediator of Salmonella-induced epithelial activation and systemic inflammation: I kappa B alpha degradation, induction of nitric oxide synthase, induction of proinflammatory mediators, and cardiovascular dysfunction
Eaves-Pyles T., Murthy K., Liaudet L., Virag L., Ross G., Soriano F. G., Szabo C., Salzman A. L., 2001/01. Journal of Immunology, 166 (2) pp. 1248-60.
 
Local and systemic inflammation: role of poly (ADP-ribose) synthetase activation by reactive nitrogen species
Mabley Jon, Liaudet Lucas, Soriano Francisco Garcia, Virág László, Jagtap Prakash, Marton Anita, Lorigados Clara Batista, Gallyas Ferenc, Szabó Éva, Abdelkarim Galaleldin E. et al., 2001. pp. 77-98 dans Nitric Oxide and Inflammation, Birkhäuser Basel.
 
Negative pressure post-tracheal extubation alveolar hemorrhage.
Broccard A.F., Liaudet L., Aubert J.D., Schnyder P., Schaller M.D., 2001. Anesthesia and Analgesia, 92 (1) pp. 273-275. Peer-reviewed.
 
Poly (ADP-Ribose) Synthetase as a Novel Therapeutic Target for Circulatory Shock
Liaudet L., Soriano F. G., Szabó C., 2001. pp. 78-89 dans Yearbook of Intensive Care and Emergency Medicine 2001, Springer Berlin Heidelberg.
 
Use of botulinum toxin type A to avoid tracheal intubation or tracheostomy in severe paradoxical vocal cord movement
Maillard I., Schweizer V., Broccard A., Duscher A., Liaudet L., Schaller M. D., 2000/09. Chest, 118 (3) pp. 874-7.
 
Poly (ADP-ribose) synthetase mediates intestinal mucosal barrier dysfunction after mesenteric ischemia
Liaudet L., Szabo A., Soriano F. G., Zingarelli B., Szabo C., Salzman A. L., 2000/08. Shock, 14 (2) pp. 134-41.
 
Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase
Liaudet L., Soriano F. G., Szabo E., Virag L., Mabley J. G., Salzman A. L., Szabo C., 2000/08. Proceedings of the National Academy of Sciences of the United States of America, 97 (18) pp. 10203-8.
 
Effects of norepinephrine on the distribution of intestinal blood flow and tissue adenosine triphosphate content in endotoxic shock
Revelly J. P., Liaudet L., Frascarolo P., Joseph J. M., Martinet O., Markert M., 2000/07. Critical Care Medicine, 28 (7) pp. 2500-6.
 
Selective inhibition of inducible nitric oxide synthase: A promising strategy in the therapy of septic shock?
Liaudet L., Schaller M. -D., 2000/04/28. Intensivmedizin und Notfallmedizin, 37 (3) pp. 166-175.
 
Biology of nitric oxide signaling
Liaudet L., Soriano F. G., Szabo C., 2000/04. Critical Care Medicine, 28 (4 Suppl) pp. N37-52.
 
Tissue oxygenation and hemodynamic response to NO synthase inhibition in septic shock.
Broccard A., Hurni J.M., Eckert P., Liaudet L., Schaller M.D., Lazor R., Perret C., Feihl F., 2000. Shock (augusta, Ga.), 14 (1) pp. 35-40. Peer-reviewed.
 
Cranial nerve palsies and descending paralysis in a drug abuser resulting from wound botulism
Martin C., Schaller M. D., Lepori M., Liaudet L., 1999/07. Intensive Care Medicine, 25 (7) p. 765.
 
Drug points: severe ergotism associated with interaction between ritonavir and ergotamine
Liaudet L., Buclin T., Jaccard C., Eckert P., 1999/03. BMJ, 318 (7186) p. 771. Peer-reviewed.
 
Hypoxic contraction of small pulmonary arteries from normal and endotoxemic rats: fundamental role of NO.
Terraz S., Baechtold F., Renard D., Barsi A., Rosselet A., Gnaegi A., Liaudet L., Lazor R., Haefliger J.A., Schaad N. et al., 1999. AJP: Heart and Circulatory Physiology, 276 (4) pp. H1207-H1214.
 
Dysoxie tissulaire : détection et traitement
Liaudet L., Schaller M.D., Revelly J.P., 1998. Médecine et Hygiène, 56 (2226) pp. 1910-1914.
 
Interprétation du pH intraveineux gastrique.
Liaudet L, Feihl F (débatteur), 1998. Hémodynamic Forum, 3 pp. 1-7.
 
Monoxyde d'azote (NO) et choc septique
Liaudet L., Schaller M.D., 1998. Médecine et Hygiène, 56 (2226) pp. 1916-1918.
Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock
Liaudet L., Rosselet A., Schaller M. D., Markert M., Perret C., Feihl F., 1998/01. Journal of Infectious Diseases, 177 (1) pp. 127-32.
 
Selective iNOS inhibition is superior to norepinephrine in the treatment of rat endotoxic shock
Rosselet A., Feihl F., Markert M., Gnaegi A., Perret C., Liaudet L., 1998/01. American Journal of Respiratory and Critical Care Medicine, 157 (1) pp. 162-70.
 
Selective pharmacological inhibition of inducible nitric oxide synthase in experimental septic shock.
Liaudet L, Feihl F, Schaller MD, 1998. dans Yearbook of Intensive Care and Emergency Medicine.
 
Stratégies ventilatoires actuelles du syndrome de détresse respiratoire aigu
Eckert P., Burdet L., Liaudet L., Broccard A., 1998. Médecine et Hygiène, 56 (2226) pp. 1920-1924.
 
Effect of L-lysine on nitric oxide overproduction in endotoxic shock
Liaudet L., Gnaegi A., Rosselet A., Markert M., Boulat O., Perret C., Feihl F., 1997/10. British Journal of Pharmacology, 122 (4) pp. 742-8.
 
L-canavanine improves organ function and tissue adenosine triphosphate levels in rodent endotoxemia
Liaudet L., Fishman D., Markert M., Perret C., Feihl F., 1997/05. American Journal of Respiratory and Critical Care Medicine, 155 (5) pp. 1643-8.
 
Cerebral thromboembolism after direct current cardioversion for pure atrial flutter
Liaudet L., Kehtari R., Enrico J. F., 1997/02. Intensive Care Medicine, 23 (2) pp. 196-7.
 
L-canavanine, an inhibitor of inducible nitric oxide synthase, improves venous return in endotoxemic rats.
Fishman D., Liaudet L., Lazor R., Perret C.H., Feihl F., 1997. Critical care medicine, 25 (3) pp. 469-75. Peer-reviewed.
 
Manifestations cliniques de l'actinomycose: revue de la litterature a propos d'un cas. [Clinical manifestations of actinomycosis: literature review apropos of a case]
Liaudet L., Erard P., Fellrath J. M., Kaeser P., 1996/06. Revue Médicale de la Suisse Romande, 116 (6) pp. 423-8.
 
Beneficial effects of L-canavanine, a selective inhibitor of inducible nitric oxide synthase, during rodent endotoxaemia.
Liaudet L., Feihl F., Rosselet A., Markert M., Hurni J.M., Perret C., 1996/05. Clinical Science, 90 (5) pp. 369-377. Peer-reviewed.
 
Cutaneous and muscular abscesses secondary to Actinomyces meyeri pneumonia
Liaudet L., Erard P., Kaeser P., 1996/01. Clinical Infectious Diseases, 22 (1) pp. 185-6.
 
Inhibition de la NO synthase dans le choc septique
Liaudet L., Fishman D., Feihl F., Perret C., 1996. Médecine et Hygiène, 54 pp. 454-456.
 
Le remplissage vasculaire au cours du choc septique. Bases physiopathologiques et réalité clinique.
Fishman D., Liaudet L., Feihl F., Perret C., 1996. Médecine et Hygiène, 54 pp. 432-437.
 
Lesion myocardique secondaire a une defibrillation. Revue de la litterature et implications pratiques. [Myocardial lesion secondary to defibrillation. Literature review and practical implications]
Liaudet L., Kehtari R., Enrico J. F., 1993/11. Revue Médicale de la Suisse Romande, 113 (11) pp. 933-43.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University